Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
The Journal of Clinical Endocrinology and Metabolism|September 15, 2018
A meta-analysis of the prevalence of cardiac valvulopathy in hyperprolactinemic patients treated with CabergolineC E Stiles, E T Tetteh-Wayoe, J Bestwick, et al.
European Journal of Endocrinology|May 5, 2009
Successful use of weekly pegvisomant administration in patients with acromegalyC E Higham, J D J Thomas, M Bidlingmaier, et al.
Thorax|March 1, 1997
Pulmonary artery occlusion by tuberculous mediastinal lymphadenopathyW M Drake, S L Elkin, A al-Kutoubi, et al.
QJM : Monthly Journal of the Association of Physicians|February 4, 2010
Intra-abdominal fibrosis in a recent cohort of patients with neuroendocrine ('carcinoid') tumours of the small bowelM R Druce, N Bharwani, S A Akker, et al.
The Journal of Clinical Endocrinology and Metabolism|April 5, 2002
A comparison of the effects of pegvisomant and octreotide on glucose, insulin, gastrin, cholecystokinin, and pancreatic polypeptide responses to oral glucose and a standard mixed mealC Parkinson, W M Drake, M E Roberts, et al.
Endocrinology|January 14, 1999
Desensitization of CGRP and adrenomedullin receptors in SK-N-MC cells: implications for the RAMP hypothesisW M Drake, A Ajayi, S R Lowe, et al.
Clinical Endocrinology|April 10, 2002
Serum lipoprotein changes following IGF-I normalization using a growth hormone receptor antagonist in acromegalyC Parkinson, W M Drake, G Wieringa, et al.
European Journal of Endocrinology|October 3, 2001
Successful treatment of resistant acromegaly with a growth hormone receptor antagonistW M Drake, C Parkinson, S A Akker, et al.
European Journal of Endocrinology|March 15, 2005
Disease activity in acromegaly may be assessed 6 weeks after discontinuation of pegvisomantW M Drake, R A Loureiro, C Parkinson, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 1998
Emergency and prolonged use of intravenous etomidate to control hypercortisolemia in a patient with Cushing's syndrome and peritonitisW M Drake, L A Perry, C J Hinds, et al.
Pageof 8